Salomon Z. Langer
Direttore/Membro del Consiglio presso Mindset BioPharmaceuticals Ltd.
Profilo
Salomon Z.
Langer is a Director of Mindset BioPharmaceuticals Ltd.
and Vice President of Molecular Biology and Drug Discovery for Compugen Ltd.
He is President of the Latin American Society of Pharmacology, Vice President of the Collegium Internationale Neuro-Psychopharmacologicum, and a Professor of the University of Buenos Aires.
Previously, Dr. Langer was President of Research and Development for Synthelabo SA and Head of the Department of Pharmacology for the Wellcome Research Laboratories.
Posizioni attive di Salomon Z. Langer
| Società | Posizione | Inizio |
|---|---|---|
Mindset BioPharmaceuticals Ltd.
 Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Mindset BioPharmaceuticals Ltd. develops disease modifying therapies. It specializes in molecular neuropharmacology, behavioral science, clinical neurology, drug delivery, and biopharmaceutical development. The company was founded by Daniel G. Chain in February 1997 and is headquartered in Jerusalem, Israel. | Direttore/Membro del Consiglio | - |
| Collegium Internationale Neuro-Psychopharmacologicum | Corporate Officer/Principal | - |
Precedenti posizioni note di Salomon Z. Langer
| Società | Posizione | Fine |
|---|---|---|
Synthélabo SA
 Synthélabo SA Pharmaceuticals: OtherHealth Technology Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France. | Corporate Officer/Principal | - |
| Wellcome Research Laboratories | Corporate Officer/Principal | - |
| Universidad de Buenos Aires | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Mindset BioPharmaceuticals Ltd.
Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Mindset BioPharmaceuticals Ltd. develops disease modifying therapies. It specializes in molecular neuropharmacology, behavioral science, clinical neurology, drug delivery, and biopharmaceutical development. The company was founded by Daniel G. Chain in February 1997 and is headquartered in Jerusalem, Israel. | Health Services |
| Collegium Internationale Neuro-Psychopharmacologicum | |
Synthélabo SA
Synthélabo SA Pharmaceuticals: OtherHealth Technology Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France. | Health Technology |
| Wellcome Research Laboratories |
- Borsa valori
- Insiders
- Salomon Z. Langer
